Viatris Inc. (VTRS) CEO Michael Goettler on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/09/21
Viatris (VTRS) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 07/30/21
Viatris gets FDA approval of first biosimilar version of Sanofi's insulin LantusMarket Watch • 07/29/21
Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar InjectionBenzinga • 07/29/21
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of DiabetesPRNewsWire • 07/29/21